Document:

Exhibit 10.1

 

STOCK PURCHASE AGREEMENT

  

This AGREEMENT, dated
as of August 2, 2019, (the “Agreement”) by and between Cinedigm Corp., a Delaware corporation (the “Company”),
and Bison Entertainment and Media Group, a Cayman Islands company (the “Purchaser”).

 

WHEREAS, the Company
desires to sell and the Purchaser desires to purchase shares of the Company’s Class A common stock, $0.001 par value (the
“Common Stock”), on the terms and conditions hereinafter set forth.

 

WHEREAS, the Company
has entered into that certain Agreement and Plan of Merger, dated as of March 14, 2019 (the “Merger Agreement”),
by and among the Company, C&F Merger Sub, Inc., a wholly-owned subsidiary of the Company (“Merger Sub”),
Future Today Inc (“Future Today”), Alok Ranjan and Vikrant Mathur (individually and as Stockholder Representative)
and the Company Stockholders identified therein, pursuant to which Future Today will merge with Merger Sub and, as a result, become
wholly-owned by the Company, and in connection with which the Company and the Surviving Company (as defined in the Merger Agreement)
will enter into this Agreement and a financing arrangement, respectively (together, the “Acquisition Financing”
and, the transactions contemplated pursuant to the Merger Agreement and in the Acquisition Financing, the “Transactions”).

 

NOW, THEREFORE, in
consideration of the mutual covenants and representations herein set forth, it is hereby agreed as follows:

 

1.                 
Purchase and Sale of Common Stock. Subject to the terms and conditions of this Agreement, the Company hereby agrees
to sell to the Purchaser, and the Purchaser agrees to purchase from the Company, an aggregate of 1,900,000 shares of Common Stock
(the “Shares”) at a purchase price per share (the “Purchase Price”) of the $1.50, for an
aggregate amount of $2,850,000.

 

2.                 
Closing. The closing of the purchase and sale of the Shares by the Purchaser and the Company (a “Closing”)
will occur on the date hereof (the “Closing Date”).

 

3.                 
Closing Conditions.

 

		a.	The Closing is subject to the following conditions being met (the “Closing
Conditions”):

 

     

     

    

 

		(1)	The accuracy in all material respects when made and on the relevant Closing
Date of the representations and warranties of the Purchaser and the Company contained herein;

 

		(2)	The delivery by the Purchaser to the Company of the applicable Purchase Price;
and

 

		(3)	The delivery by the Company of an irrevocable written instruction to the
Company’s transfer agent for the Common Stock with respect to the issuance of a certificate representing the applicable Shares,
registered in the name of the Purchaser.

 

		b.	Upon the earlier of (x) the closing of the Transactions or (y) the Merger
Agreement shall have been terminated without a closing, the Company and the Purchaser shall promptly enter into the Registration
Rights Agreement (as defined below) with respect to the Shares.

 

4.                 
Representations and Warranties of Purchaser. The Purchaser hereby represents and warrants that as of the date hereof
and as of each relevant Closing Date:

 

a.                  
Own Account. The Purchaser understands that the Shares are “restricted securities” and have not been
registered under the Securities Act of 1933, as amended (the “Act”), or any applicable state securities law.
The Purchaser is acquiring the Shares for his or its own account and not with a view to or for distributing or reselling such Shares
or any part thereof in violation of the Act or any applicable state securities law, has no present intention of distributing any
of such Shares in violation of the Act or any applicable state securities law and has no arrangement or understanding with any
other persons or entities regarding the distribution of the Shares (this representation and warranty not limiting the Purchaser’s
right to sell the Shares in compliance with applicable federal and state securities laws) in violation of the Act or any applicable
state securities law.

 

b.                 
Purchaser Status. At the time the Purchaser was offered the Shares, he or it was, and at the date hereof he or it
is, an “accredited investor” as defined in Rule 501 under the Act.

 

c.                  
Experience of Such Purchaser. The Purchaser has such knowledge, sophistication and experience in business and financial
matters so as to be capable of evaluating the merits and risks of the prospective investment in the Shares, and has so evaluated
the merits and risks of such investment. The Purchaser is able to bear the economic risk of an investment in the Shares and, at
the present time, is able to afford a complete loss of such investment. The Purchaser has had access to information about the Company
sufficient to make an investment decision with respect to the Shares.

 

d.                 
General Solicitation. The Purchaser is not purchasing the Shares as a result of any advertisement, article, notice
or other communication regarding the Shares published in any newspaper, magazine or similar media or broadcast over television
or radio or presented at any seminar or any other general solicitation or general advertisement.

 

    -2-

     

    

 

e.                  
Certain Trading Activities. The Purchaser has not directly or indirectly, nor has any person or entity acting on
behalf of or pursuant to any understanding with the Purchaser, engaged in any direct or indirect purchases or sales in the securities
of the Company (including, without limitations, any short sales involving the Company’s securities) since the time that the
Purchaser was first contacted by or on behalf of the Company or any other person or entity regarding the investment in the Company
contemplated by this Agreement.

 

f.                   
Authorization; Enforcement. The Purchaser has the requisite power and authority to enter into and to consummate the
transactions contemplated by this Agreement and otherwise to carry out his or its obligations hereunder. The execution and delivery
of this Agreement by the Purchaser and the consummation by him or it of the transactions contemplated hereby have been duly authorized
by all necessary action on the part of the Purchaser and no further action is required by the Purchaser. This Agreement has been
duly executed by the Purchaser and, when delivered in accordance with the terms hereof, will constitute the valid and binding obligation
of the Purchaser, enforceable against the Purchaser in accordance with its terms except (i) as limited by applicable bankruptcy,
insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally
and (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies.

 

5.                 
Representations and Warranties of Company. The Company hereby represents and warrants that as of the date hereof
and as of each Closing Date:

 

a.                  
Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate
the transactions contemplated by this Agreement and otherwise to carry out its obligations hereunder. The execution and delivery
of this Agreement by the Company and the consummation by it of the transactions contemplated hereby have been duly authorized by
all necessary action on the part of the Company and no further action is required by the Company or its board of directors in connection
therewith. This Agreement has been duly executed by the Company and, when delivered in accordance with the terms hereof, will constitute
the valid and binding obligation of the Company, enforceable against the Company in accordance with its terms except (i) as limited
by applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of
creditors’ rights generally and (ii) as limited by laws relating to the availability of specific performance, injunctive
relief or other equitable remedies.

 

b.                 
Private Placement. Assuming the accuracy of the Purchaser’s representations and warranties set forth in Section
4, no registration under the Act is required for the offer and sale of the Shares by the Company to the Purchaser as contemplated
hereby.

 

    -3-

     

    

 

6.                 
Securities Legend; Lockup.

 

a.                  
Legend. Until such time as the Shares shall have been transferred in accordance with an opinion of counsel satisfactory
to the Company that registration under the Act is not required, so long as required under the Act or the regulations promulgated
thereunder, the certificate(s) representing the Shares shall bear substantially the following legend:

 

 

THE
SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED with the securities and exchange commission or the securities
commission of any state in reliance upon an exemption from registration under the securities act of 1933, as amended (the “Securities
act”), and, accordingly, may not be offered or sold except pursuant to an effective registration statement under the SECURITIES
act or pursuant to an available exemption from, or in a transaction not subject to, the registration requirements of the securities
act and in accordance with applicable state securities laws as evidenced by a legal opinion of counsel to the transferor to such
effect, the substance of which shall be reasonably ACCEPTABLE to the company.

 

 

b.                 
Lockup. During the Lockup Period (as defined below), the Purchaser will not offer, pledge, sell, contract to sell,
sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase,
transfer by gift or contribution, or otherwise transfer or dispose of, directly or indirectly, any of the Shares. The “Lockup
Period” means the period commencing on the date of issuance of any Shares, with respect to such Shares, and ending on the
first anniversary of the earlier of (x) the Closing Date or (y) the closing date of the Transactions; provided, however, that if
the Merger Agreement shall have been terminated without a closing, the Lockup Period shall end with respect to the Shares upon
the termination of the Merger Agreement.

 

7.                 
Registration Rights. The Purchaser will be entitled to registration rights with respect to the Shares pursuant to
the Registration Rights Agreement as defined in the Merger Agreement (the “Registration Rights Agreement”).

 

8.                 
Termination. This Agreement may be terminated by either the Company or the Purchaser by written notice to the other
party if (x) the Merger Agreement is terminated for any reason and the Transactions are not consummated and (y) no Shares have
been sold at the Closing.

 

9.                 
Governing Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State
of New York without giving effect to any principle or rule (whether of the State of New York or any other jurisdiction) that would
cause the application of laws of any jurisdiction other than those of the State of New York.

 

    -4-

     

    

 

10.             
Notice. Notice hereunder shall be deemed to have been duly given if in writing and delivered in person or by registered
or certified mail, postage prepaid, return receipt requested, if to the Company, at its office at 45 West 36th Street,
7th Floor, New York, New York, 10018, Attn: General Counsel, or if to the Purchaser, at the address set forth on the
Purchaser’s signature page (or at such other addresses as the parties may notify each other in accordance with the provisions
of this Section 10).

 

11.             
Entire Agreement; Amendment. This Agreement supersedes all prior written and oral agreements and understandings among
the parties as to its subject matter and constitutes the entire agreement of the parties with respect to the subject matter hereof.
This Agreement may not be modified, amended, terminated or any provision hereof waived in whole or in part except by a written
agreement signed by the Company and the Purchaser.

 

12.             
Waivers. No waiver hereunder shall (i) be valid unless in a writing signed by the waiving party, and (ii) be deemed
a waiver of any subsequent breach or default of the same or a similar nature.

 

13.             
Severability; Reformation. If any provision of this Agreement shall be determined by a court of law to be unenforceable
for any reason, such unenforceability shall not affect the enforceability of any of the remaining provisions hereof; and this Agreement,
to the fullest extent lawful, shall be reformed and construed as if such unenforceable provision, or part of a provision, had never
been contained herein, and such provision or part reformed so that it would be enforceable to the maximum extent legally possible.

 

14.             
Headings. Headings are for convenience only and are not deemed to be part of this Agreement.

 

15.             
Counterparts. This Agreement may be executed in any number of counterparts, all of which will be one and the same
agreement. Delivery of a signature page by facsimile or other electronic means shall be deemed to be the equivalent of a manually
executed original signature page. This Agreement will become effective when each party to this Agreement will have received counterparts
signed by all of the other parties.

  

 

[SIGNATURE PAGES FOLLOW]

 

    -5-

     

    

 

IN WITNESS WHEREOF, this Agreement has been
executed by the undersigned as of the date and year first above written.

 

 

	 	 	CINEDIGM CORP.
	
         

         

         
	 	By: 	/s/ Gary S. Loffredo
	 	 	Name:	  Gary S. Loffredo
	 	 	Title:	  Chief Operating Officer

  

    -6-

     

    

 

	 	 	Bison Entertainment and Media Group
	
         

         

         

         
	 	By: 	/s/ Peixin Xu
	 	 	Name:	Peixin Xu
	 	 	Title:	Director

 

 

	 	Address for Notices:
	 	
        609-610 Tower B, 21st Century Tower

         

        40 Liangmaqiao Rd., Chaoyang District

         

        Beijing F4 100016_______________

         

        China_________________________

         

 

    -7-EX-10.1

 Exhibit 10.1 

SIENNA BIOPHARMACEUTICALS, INC. 

NON-EMPLOYEE DIRECTOR COMPENSATION
PROGRAM 
 (AS AMENDED AND RESTATED
EFFECTIVE MAY 30, 2019) 
 This Sienna Biopharmaceuticals, Inc. (the “Company”) Non-Employee Director Compensation Program (this “Program”) has been adopted under the Company’s 2017 Incentive Award Plan (the “Plan”) and became effective upon the closing of
the Company’s initial public offering of its common stock (the “IPO”), and further amended and restated effective as of May 30, 2019. The Equity Compensation portion of this Program is intended to constitute the Non-Employee Director Equity Compensation Program contemplated by Section 4.6 of the Plan. Capitalized terms not otherwise defined herein shall have the meaning ascribed in the Plan. 

Cash Compensation 
 Effective upon the IPO, annual
retainers will be paid in the following amounts to Non-Employee Directors: 
  

					
	 Non-Employee Director:
	  	$	35,000	 
	 Non-Executive Chair:
	  	$	30,000	 
	 Chair of Audit Committee:
	  	$	15,000	 
	 Chair of Compensation Committee:
	  	$	12,500	 
	 Chair of Nominating and Corporate Governance Committee:
	  	$	7,500	 
	 Audit Committee Member (other than Chair):
	  	$	7,500	 
	 Compensation Committee Member (other than Chair):
	  	$	6,250	 
	 Nominating and Corporate Governance Committee Member (other than Chair):
	  	$	3,750	 

 All annual retainers will be paid in cash quarterly in arrears promptly following the end of the applicable calendar quarter,
but in no event more than thirty (30) days after the end of such quarter. In the event a Non-Employee Director does not serve as a Non-Employee Director, or in the
applicable positions described above, for an entire calendar quarter, the retainer paid to such Non-Employee Director shall be prorated for the portion of such calendar quarter actually served as a Non-Employee Director, or in such position, as applicable. 
 Equity Compensation 

 

			
	Initial Stock Option Grant:	  	Each Non-Employee Director who is initially elected or appointed to serve on the Board after the IPO shall be granted an Option to purchase 50,000 shares of Common Stock under the Plan or
any other applicable Company equity incentive plan then-maintained by the Company (the “Initial Option”).

			
		
	  
	  	The Initial Option will be automatically granted on the date on which such Non-Employee Director commences service on the Board, and will vest as to 1/36th of the shares subject thereto on each monthly anniversary of the applicable date of grant such that the shares subject to the Initial Option are fully vested on the third anniversary of the
grant, subject to the Non-Employee Director continuing in service on the Board through each vesting date.
		
	Annual Stock Option Grant:	  	 Each Non-Employee Director who is serving on the Board as of the date of each annual shareholder
meeting of the Company (each, an “Annual Meeting”) shall be granted an Option to purchase 25,000 shares of Common Stock under the Plan or any other applicable Company equity incentive plan then-maintained by the Company
(the “Annual Option”).
  
 The Annual Option will be
automatically granted on the date of the applicable Annual Meeting, and will vest as to 1/12th of the shares subject thereto on each monthly anniversary of the applicable date of grant such
that the shares subject to the Annual Option are fully vested on the first anniversary of the grant, subject to the Non-Employee Director continuing in service on the Board through such vesting
date.

 The per share exercise price of each Option granted to a Non-Employee Director shall
equal the Fair Market Value (as defined in the Plan) of a share of common stock on the date the Option is granted. 
 The term of each Option granted to a Non-Employee Director shall be ten (10) years from the date the Option is granted. 
 No portion of an Initial Option
or Annual Option which is unvested or unexercisable at the time of a Non-Employee Director’s termination of service on the Board shall become vested and exercisable thereafter. 

 Members of the Board who are employees of the Company or any parent or subsidiary of the Company who
subsequently terminate their service with the Company and any parent or subsidiary of the Company and remain on the Board will not receive an Initial Option, but to the extent that they are otherwise eligible, will be eligible to receive, after
termination from service with the Company and any parent or subsidiary of the Company, Annual Options as described above. 
 Change in Control

 Upon a Change in Control of the Company, all outstanding equity awards granted under the Plan or any other equity incentive plan maintained by the
Company that are held by a Non-Employee Director shall become fully vested and/or exercisable, irrespective of any other provisions of the Non-Employee Director’s
Award Agreement. 
 Reimbursements 
 The Company
shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses
incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company’s applicable expense reimbursement policies and procedures as in effect from
time to time. 
 Miscellaneous 
 The other
provisions of the Plan shall apply to the Options granted automatically pursuant to this Program, except to the extent such other provisions are inconsistent with this Program. All applicable terms of the Plan apply to this Program as if fully set
forth herein, and all grants of Options hereby are subject in all respect to the terms of such Plan. The grant of any Option under this Program shall be made solely by and subject to the terms set forth in a written agreement in a form to be
approved by the Board and duly executed by an executive officer of the Company. 
 Effectiveness, Amendment, Modification and Termination 

This Program shall become effective upon the consummation of the IPO. This Program may be amended, modified or terminated by the Board in the future at its
sole discretion. No Non-Employee Director shall have any rights hereunder, except with respect to an Option granted pursuant to the Program.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}]]